131 related articles for article (PubMed ID: 35970393)
21. KDM1A regulated the osteo/dentinogenic differentiation process of the stem cells of the apical papilla via binding with PLOD2.
Wang L; Yang H; Lin X; Cao Y; Gao P; Zheng Y; Fan Z
Cell Prolif; 2018 Aug; 51(4):e12459. PubMed ID: 29656462
[TBL] [Abstract][Full Text] [Related]
22. Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-κB pathways and LncRNA-AF085935/GPC3 axis.
Al-Noshokaty TM; Mesbah NM; Abo-Elmatty DM; Abulsoud AI; Abdel-Hamed AR
Life Sci; 2022 Aug; 303():120675. PubMed ID: 35640776
[TBL] [Abstract][Full Text] [Related]
23. Y-box binding protein 1 augments sorafenib resistance
Liu T; Xie XL; Zhou X; Chen SX; Wang YJ; Shi LP; Chen SJ; Wang YJ; Wang SL; Zhang JN; Dou SY; Jiang XY; Cui RL; Jiang HQ
World J Gastroenterol; 2021 Jul; 27(28):4667-4686. PubMed ID: 34366628
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
[TBL] [Abstract][Full Text] [Related]
25. SOX9 enhances sorafenib resistance through upregulating ABCG2 expression in hepatocellular carcinoma.
Wang M; Wang Z; Zhi X; Ding W; Xiong J; Tao T; Yang Y; Zhang H; Zi X; Zhou W; Huang G
Biomed Pharmacother; 2020 Sep; 129():110315. PubMed ID: 32554246
[TBL] [Abstract][Full Text] [Related]
26. [Function of histone demethylasehistone lysine-specific demethylase 1A in tumor initiation and progression].
Zhang X; An X; Zhu S; Liu Y
Sheng Wu Gong Cheng Xue Bao; 2020 Feb; 36(2):226-240. PubMed ID: 32147995
[TBL] [Abstract][Full Text] [Related]
27. GR and LSD1/KDM1A-Targeted Gene Activation Requires Selective H3K4me2 Demethylation at Enhancers.
Clark EA; Wu F; Chen Y; Kang P; Kaiser UB; Fang R; Shi YG
Cell Rep; 2019 Jun; 27(12):3522-3532.e3. PubMed ID: 31216473
[TBL] [Abstract][Full Text] [Related]
28. CD24 regulates sorafenib resistance via activating autophagy in hepatocellular carcinoma.
Lu S; Yao Y; Xu G; Zhou C; Zhang Y; Sun J; Jiang R; Shao Q; Chen Y
Cell Death Dis; 2018 May; 9(6):646. PubMed ID: 29844385
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological Inhibition of the Histone Lysine Demethylase KDM1A Suppresses the Growth of Multiple Acute Myeloid Leukemia Subtypes.
McGrath JP; Williamson KE; Balasubramanian S; Odate S; Arora S; Hatton C; Edwards TM; O'Brien T; Magnuson S; Stokoe D; Daniels DL; Bryant BM; Trojer P
Cancer Res; 2016 Apr; 76(7):1975-88. PubMed ID: 26837761
[TBL] [Abstract][Full Text] [Related]
30. Aberrant expression of KDM1A inhibits ferroptosis of lung cancer cells through up-regulating c-Myc.
Lu C; Cai Y; Liu W; Peng B; Liang Q; Yan Y; Liang D; Xu Z
Sci Rep; 2022 Nov; 12(1):19168. PubMed ID: 36357457
[TBL] [Abstract][Full Text] [Related]
31. KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway.
Zhang W; Ruan X; Li Y; Zhi J; Hu L; Hou X; Shi X; Wang X; Wang J; Ma W; Gu P; Zheng X; Gao M
Theranostics; 2022; 12(4):1500-1517. PubMed ID: 35198054
[No Abstract] [Full Text] [Related]
32. Expression, Purification, and Biochemical Analysis of the LSD1/KDM1A Histone Demethylase.
Laurent B; Shi Y
Methods Enzymol; 2016; 573():241-59. PubMed ID: 27372756
[TBL] [Abstract][Full Text] [Related]
33. KDM1A promotes tumor cell invasion by silencing TIMP3 in non-small cell lung cancer cells.
Kong L; Zhang P; Li W; Yang Y; Tian Y; Wang X; Chen S; Yang Y; Huang T; Zhao T; Tang L; Su B; Li F; Liu XS; Zhang F
Oncotarget; 2016 May; 7(19):27959-74. PubMed ID: 27058897
[TBL] [Abstract][Full Text] [Related]
34. ZNF143-Mediated H3K9 Trimethylation Upregulates CDC6 by Activating MDIG in Hepatocellular Carcinoma.
Zhang L; Huo Q; Ge C; Zhao F; Zhou Q; Chen X; Tian H; Chen T; Xie H; Cui Y; Yao M; Li H; Li J
Cancer Res; 2020 Jun; 80(12):2599-2611. PubMed ID: 32312832
[TBL] [Abstract][Full Text] [Related]
35. NET-1 promotes invasion, adhesion and growth of hepatocellular carcinoma by regulating the expression of BAX, caspase 3, caspase 8 and BCL2.
Wang M; Sun X; Jiang Y; Tan Z
Cell Mol Biol (Noisy-le-grand); 2018 Sep; 64(12):37-41. PubMed ID: 30301500
[TBL] [Abstract][Full Text] [Related]
36. PRMT2 accelerates tumorigenesis of hepatocellular carcinoma by activating Bcl2 via histone H3R8 methylation.
Hu G; Yan C; Xie P; Cao Y; Shao J; Ge J
Exp Cell Res; 2020 Sep; 394(2):112152. PubMed ID: 32574605
[TBL] [Abstract][Full Text] [Related]
37. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.
Lai SC; Su YT; Chi CC; Kuo YC; Lee KF; Wu YC; Lan PC; Yang MH; Chang TS; Huang YH
J Exp Clin Cancer Res; 2019 Nov; 38(1):474. PubMed ID: 31771617
[TBL] [Abstract][Full Text] [Related]
38. Activity-dependent Regulation of Histone Lysine Demethylase KDM1A by a Putative Thiol/Disulfide Switch.
Ricq EL; Hooker JM; Haggarty SJ
J Biol Chem; 2016 Nov; 291(47):24756-24767. PubMed ID: 27634040
[TBL] [Abstract][Full Text] [Related]
39. FKBP8 recruits LC3A to mediate Parkin-independent mitophagy.
Bhujabal Z; Birgisdottir ÅB; Sjøttem E; Brenne HB; Øvervatn A; Habisov S; Kirkin V; Lamark T; Johansen T
EMBO Rep; 2017 Jun; 18(6):947-961. PubMed ID: 28381481
[TBL] [Abstract][Full Text] [Related]
40. LSD1: more than demethylation of histone lysine residues.
Perillo B; Tramontano A; Pezone A; Migliaccio A
Exp Mol Med; 2020 Dec; 52(12):1936-1947. PubMed ID: 33318631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
